No phaseRecruiting
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
Hydration Intervention to Address Dehydration Associated With Use of GLP-1 Based Medications
- Sponsor
- State University of New York at Buffalo (Academic or other)
- Enrolment
- 30 planned
- Conditions
- Obesity & Overweight; Type 2 Diabetes; Type 2 Diabetes (Adult Onset); Obesity Type 2 Diabetes Mellitus; Dehydration
- Interventions
- Hydration Plus; Control
- Ages
- adults
- Registry
- NCT07641361
From the registry
This is a 17 - week study consisting of a one - week run - in period and a 16 - week intervention. The 16 - week pilot interventions aims to increase hydration in those beginning GLP - 1 RA therapy. Investigators aim to increase hydration to potentially decrease side effect severity, amount of side effects, and drug discontinuation associated with GLP - 1 RA therapy. The investigators are piloting to assess feasibility and preliminary efficacy of the intervention through examining participant retention, participant feedback, researcher and participant adherence to protocols, impact on hydration biomarkers, and participant reported GLP - 1 RA side effects.
Primary outcomes
- Acceptability of hydration plus
- Feasibility of Intervention
- Change in physiological hydration score
- Change in perceived hydration level